Copyright
©The Author(s) 2022.
World J Stem Cells. May 26, 2022; 14(5): 347-361
Published online May 26, 2022. doi: 10.4252/wjsc.v14.i5.347
Published online May 26, 2022. doi: 10.4252/wjsc.v14.i5.347
Figure 3 Effect of Wharton's jelly-derived mesenchymal stromal/stem cells on homeostasis-driven proliferation of lymphocytes in lymphopenic mice.
Wharton's jelly-derived mesenchymal stromal/stem cells (WJ-MSCs) were mixed with carboxyfluorescein diacetate succinimidyl ester (CFSE) labeled lymphocytes were injected into 6 Gy exposed mice. In another group, only CFSE labeled lymphocytes were injected into irradiated mice. A: Dot plot shows gating strategy to monitor the proliferation of lymphocytes after acquiring the samples on flow cytometer; B: Bar graph showing % of CFSE positive lymphocytes with and without WJ-MSCs; C: Flow cytometric histograms showing lymphocyte proliferation; D: Bar graph showing percent daughter cells; E: Bar graph showing spleen index (n = 4 mice per group). aP < 0.05; bP < 0.005 as compared to radiation alone.
- Citation: Maurya DK, Bandekar M, Sandur SK. Soluble factors secreted by human Wharton’s jelly mesenchymal stromal/stem cells exhibit therapeutic radioprotection: A mechanistic study with integrating network biology. World J Stem Cells 2022; 14(5): 347-361
- URL: https://www.wjgnet.com/1948-0210/full/v14/i5/347.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i5.347